Home » Topics » Substance use and poisoning, BioWorld Science

Substance use and poisoning, BioWorld Science
RSS

Priority review for Exjade

June 23, 2005

Antagonism of D3 receptors attenuates ethanol consumption in rats / News in Context

June 20, 2005

Rimonabant under clinical evaluation for maintaining smoking cessation

June 6, 2005

Neumune IND filed in U.S.

June 1, 2005

Vivitrex NDA accepted for priority review

May 31, 2005

AN-53 exerts antiopiate activity in vitro and in vivo

May 26, 2005

Novartis files oral iron chelator Exjade in U.S., Europe

May 4, 2005

Prodrugs for treating alcoholism and opioid dependency developed at the University of Kentucky

April 26, 2005

New antismoking therapy developed by Pfizer

April 20, 2005

Long-acting naltrexone reduces heavy drinking in alcohol-dependent subjects

April 13, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability
BioWorld Science
Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
Capital remains selective in ‘barbell’ biotech market
BioWorld
Signs of recovery are emerging in the biotechnology investment sector, although investors across Asia say that capital is flowing selectively to companies that...
PSB-229 reduces plaque burden in Alzheimer’s models
BioWorld Science
Pyroglutamate-modified amyloid-β (pE3-Aβ) is a highly pathogenic Aβ species that accumulates within amyloid plaques and contributes to aggregation,...